Literature DB >> 28150064

Role of Imaging in Evaluating Infiltrative Heart Disease.

Sanjay Divakaran1, Avinainder Singh2, Bradley Collins2,3, Tomas Vita2, Rodney H Falk1, Marcelo F Di Carli1,2, Ron Blankstein4,5.   

Abstract

OPINION STATEMENT: Infiltrative heart disease is caused by the deposition of abnormal substances in the heart and can lead to abnormalities in cardiac function and electrical conduction. Advances in non-invasive cardiovascular imaging have allowed for improved diagnosis of infiltrative heart disease, as well as ways to track disease progression or regression, thus enabling a mechanism to follow response to therapy. In this review, we provide an overview of the role of imaging in the diagnosis and management of cardiac sarcoidosis (CS) and cardiac amyloidosis (CA), as well as outline a proposed algorithm for using non-invasive cardiovascular imaging for evaluating these conditions.

Entities:  

Keywords:  Cardiac amyloidosis; Cardiovascular imaging; Imaging; Infiltrative heart disease

Year:  2017        PMID: 28150064      PMCID: PMC5460755          DOI: 10.1007/s11936-017-0500-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  58 in total

1.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.

Authors:  Leslie T Cooper; Kenneth L Baughman; Arthur M Feldman; Andrea Frustaci; Mariell Jessup; Uwe Kuhl; Glenn N Levine; Jagat Narula; Randall C Starling; Jeffrey Towbin; Renu Virmani
Journal:  Eur Heart J       Date:  2007-10-24       Impact factor: 29.983

2.  Quantification of the variability associated with repeat measurements of left ventricular two-dimensional global longitudinal strain in a real-world setting.

Authors:  Salvatore P Costa; Timothy A Beaver; Joyce L Rollor; Pantila Vanichakarn; Patrick C Magnus; Robert T Palac
Journal:  J Am Soc Echocardiogr       Date:  2013-10-09       Impact factor: 5.251

3.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

4.  Two-dimensional echocardiographic findings in systemic sarcoidosis.

Authors:  D J Burstow; A J Tajik; K R Bailey; R A DeRemee; C P Taliercio
Journal:  Am J Cardiol       Date:  1989-02-15       Impact factor: 2.778

Review 5.  Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.

Authors:  Sameer Raina; Shelly Y Lensing; Ramez S Nairooz; Naga Venkata K Pothineni; Abdul Hakeem; Sabha Bhatti; Tarun Pandey
Journal:  JACC Cardiovasc Imaging       Date:  2016-08-24

6.  Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

Authors:  Christian Gagliardi; Elena Tabacchi; Rachele Bonfiglioli; Stefania Diodato; Cristina Nanni; Pierluigi Guidalotti; Massimiliano Lorenzini; Filippo Lodi; Agnese Milandri; Claudio Rapezzi; Stefano Fanti
Journal:  J Nucl Cardiol       Date:  2016-03-14       Impact factor: 5.952

7.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

8.  Doppler echocardiographic detection of left ventricular diastolic dysfunction in patients with pulmonary sarcoidosis.

Authors:  G J Fahy; T Marwick; C J McCreery; P J Quigley; B J Maurer
Journal:  Chest       Date:  1996-01       Impact factor: 9.410

9.  Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.

Authors:  K J Silverman; G M Hutchins; B H Bulkley
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

10.  Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.

Authors:  Marianna Fontana; Silvia Pica; Patricia Reant; Amna Abdel-Gadir; Thomas A Treibel; Sanjay M Banypersad; Viviana Maestrini; William Barcella; Stefania Rosmini; Heerajnarain Bulluck; Rabya H Sayed; Ketna Patel; Shameem Mamhood; Chiara Bucciarelli-Ducci; Carol J Whelan; Anna S Herrey; Helen J Lachmann; Ashutosh D Wechalekar; Charlotte H Manisty; Eric B Schelbert; Peter Kellman; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  Circulation       Date:  2015-09-11       Impact factor: 29.690

View more
  1 in total

1.  Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.

Authors:  G Wisenberg; J D Thiessen; W Pavlovsky; J Butler; B Wilk; F S Prato
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.